The released DASA and ATO present platelet-specific P-selectin on their surfaces, enabling targeted recognition and delivery to HCC cells within the tumor microenvironment, as shown in Figure 2A. Based on this, we first investigated the activation of DASA+ATO@PLT. The gene discussed is SELP; the disease is hepatocellular carcinoma.